A phase 3 trial of Johnson & Johnson's TAR-200 therapy in bladder cancer has failed to show efficacy, although the company is still confident in the potential of the programme. The SunRISe-2 study ...

Johnson & Johnson has kicked off a marketing application in the US for TAR-200 as a treatment for a form of bladder cancer, using a novel technology that releases the drug intravesically ...

As Art Chansky writes, UNC's 73-65 loss at Pittsburgh on Tuesday night proved the Panthers are the more resilient team.

Five-star recruit Caleb Wilson announced his commitment to UNC basketball early Friday morning. Here's what it means for ...

The first of two season-defining games for both Pitt and UNC will boil down to, in my mind, what each of their letters mean.

Senior writer Megan Smith traveled to Duke University to ask students in K-Ville what it's like to tent for weeks ahead of ...

The New England Patriots are parting ways with safeties coach Brian Belichick, ESPN reported Tuesday. Belichick, the youngest ...

Here is everything you need to know about UNC vs. Boston College, including TV and streaming options for the game.

Q4 2024 Earnings Call Transcript January 22, 2025 Johnson & Johnson beats earnings expectations. Reported EPS is $2.04, ...

Scheyer and his cohorts have extended offers to two other 2026 five-stars thus far in St. John Bosco High School (Calif.) ...

GZERO Publisher Evan Solomon writes that Donald Trump’s planned tariffs mean the US and Canada are headed for a trade war ...